101.budd chari associated with PV & ALL among heamatologic malignancies.

102.megaloblastic anemia ( fragmented RBC)

103.intravascular hemolytic anemia( increased haptoglobin)
104.AIDS defining hematologic malignancies= B cell Non-hodgkin lymphoma
105.In case aneamia of chronic illness .....iron and transferin(TIBC)
decreases but ferittin level increases.
106.seen in IDA....TIBC increases
107.best marker for IDA.... Serum ferittin
108.causes of IDA .....Not CKD among z choices
109.causes of fragmented RBC....Except haemophilia all
110.most common type of lymphoma--?????????NHL 62% (DLBCL)
111.a feature of both IDA and anaemia of chronic ds...serum irone decrease
112.not cause of microcytic hypochromic anemia .. hemolytic anemia
113.not true concerning CLL??????
114.MACROGLOSIA in case of megaloblastic anemia ...do serum Cobalamin
115.ANEMIA with increase haptoglobin?????
116.hemolytic anemia feature except.....thrombocytopenia
117.lab. indicators of acute hepatitis?????
118.mucosis-fungoides= indolent ( true)
119.NHL....DLBCL treatment CHOP
120.HL...Most curable +RS Cells diagnostic
121.true about lymphoma ..CD4 receptor - T cell lymphoma
122.true about NHL...GIT involvement & CHOP as treatment
123.most common types of HL..nodular sclerosis
124.not true about AML....WHO classifn more used in ethiopia.
125.DIC + Vit A receptors....M3 type
126.not myeloproliferative d/o.....CLL
127.MOST common type of AML on FAB....M2
128.AUER ROD not found on M0.....BUT mostly found on M3(Trans15:17) of AML
129.Intra thecal methotrexate prophylaxis for ALL..coz ov neurologic Mxn
130.peripheral smear ...neutro.,eosino.,baso.,platelate increased.....in which type of
leukemia.......CML t(9:22) ABL/BCR= Philadelphia chromosome
131.NOT associated with splenomegally& LAP.....Aplastic anemia
132.Hodgkin's lymphoma....cervical LN involvement common
133.legionella......hyponatremia
134.massive splenomegally least likely associated with myelo proliferative
d/o...essential thrombocytosis
135.CML initial Rx ....imatinib( tyrosine kinase inhibitor)=Gleevec
136.leukocyte ALP decreased on......in CML unlike PV & essential thrombocytosis
137.Not true about CLL....BM examination needed for Dx + treared with
chemotherapy but it needs flow cytometry + watch and see as a mg't
138.nor x-stics of CML......blast phase >10%